| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |